Skip to main content
SpringerLink
Log in

Sind miRNAs als Biomarker geeignet?

Are miRNAs suitable as biomarkers?

  • Menopause und Frauengesundheit
  • Published:
Gynäkologische Endokrinologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Ahtiainen M, Pöllänen E, Ronkainen PHA, Alen M, Puolakka J, Kaprio J, Sipilä S, Kovanen V (2012) Age and estrogen-based hormone therapy affect systemic and local IL-6 and IGF-1 pathways in women. Age (dordr) 34:1249–1260

    Article  CAS  Google Scholar 

  2. Bedene A, Mencej Bedrač S, Ješe L, Marc J, Vrtačnik P, Preželj J, Kocjan T, Kranjc T, Ostanek B (2016) MiR-148a the epigenetic regulator of bone homeostasis is increased in plasma of osteoporotic postmenopausal women. Wien Klin Wochenschr 128:519–526

    Article  PubMed  CAS  Google Scholar 

  3. Cong J, Wang C, Pu D, Liu J, Hu G, Gao C, Wu J (2014) Expression of early growth response 1 affects miR-106a/signal transducer and activator of transcription 3 regulating cognitive impairment in ovariectomized mice. Menopause 21:1143–1150

    Article  PubMed  Google Scholar 

  4. Götte M, Kiesel L (2016) Pathophysiologie der Endometriose: Neue Erkenntnisse. Gynakologische Endokrinol 14:2–8

    Article  CAS  Google Scholar 

  5. Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: Medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Hsieh Y‑C, Choudhry M a, Yu H‑P, Shimizu T, Yang S, Suzuki T, Chen J, Bland KI, Chaudry ICH (2006) Inhibition of cardiac PGC-1alpha expression abolishes ERbeta agonist-mediated cardioprotection following trauma-hemorrhage. FASEB J 20:1109–17

  7. Ibrahim SA, Hassan H, Götte M (2014) MicroRNA-dependent targeting of the extracellular matrix as a mechanism of regulating cell behavior. Biochim Biophys Acta 1840:2609–2620

    Article  PubMed  CAS  Google Scholar 

  8. Kangas R, Pöllänen E, Rippo MR, Lanzarini C, Prattichizzo F, Niskala P, Jylhävä J, Sipilä S, Kaprio J, Procopio AD, Capri M, Franceschi C, Olivieri F, Kovanen V (2014) Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy—A study with monozygotic twin pairs. Mech Ageing Dev 143–144:1–8

    Article  PubMed  CAS  Google Scholar 

  9. Kangas R, Morsiani C, Pizza G, Lanzarini C, Aukee P, Kaprio J, Sipilä S, Franceschi C, Kovanen V, Laakkonen EK, Capri M (2018) Menopause and adipose tissue: miR-19a-3p is sensitive to hormonal replacement. Oncotarget 9:2279–2294

    Article  PubMed  Google Scholar 

  10. Neubauer C, Kiesel L, Götte M (2012) MicroRNAs and the pathogenesis of endometriosis. J Endometr 4:1–16

    Article  Google Scholar 

  11. Olivieri F, Lazzarini R, Recchioni R, Marcheselli F, Rippo MR, Di Nuzzo S, Albertini MC, Graciotti L, Babini L, Mariotti S, Spada G, Abbatecola AM, Antonicelli R, Franceschi C, Procopio AD (2013) MiR-146a as marker of senescence-Associated pro-inflammatory status in cells involved in vascular remodelling. Age (dordr) 35:1157–1172

    Article  CAS  Google Scholar 

  12. Pan H, Chen B, Wang J, Wang X, Hu P, Wu S, Liu Y, Xu Z, Zhang W, Wang B, Cao YP (2016) The miR-449b polymorphism, rs10061133 A〉G, is associated with premature ovarian insufficiency. Menopause 23:1009–1011

    Article  PubMed  Google Scholar 

  13. Patten IS, Arany Z (2012) PGC-1 coactivators in the cardiovascular system. Trends Endocrinol Metab 23:90–97

    Article  PubMed  CAS  Google Scholar 

  14. Pierdomenico SD, Di Nicola M, Pierdomenico AM, Lapenna D, Cuccurullo F (2011) Cardiovascular risk in subjects with left ventricular concentric remodeling at baseline examination: A meta-analysis. J Hum Hypertens 25:585–591

    Article  PubMed  CAS  Google Scholar 

  15. Rah H, Jeon YJ, Lee BE, Kim JO, Shim SH, Lee WS, Choi DH, Kim JH, Kim NK (2013) Association of polymorphisms in microRNA machinery genes (DROSHA, DICER1, RAN, and XPO5) with risk of idiopathic primary ovarian insufficiency in Korean women. Menopause 20:1067–1073

    Article  PubMed  Google Scholar 

  16. Rah H, Kim HS, Cha SH, Kim YR, Lee WS, Ko JJ, Kim NK (2015) Association of breast cancer-related microRNA polymorphisms with idiopathic primary ovarian insufficiency. Menopause 22:437–443

    Article  PubMed  Google Scholar 

  17. Stachowiak G, Zając A, Nowak M, Stetkiewicz T, Wilczyński JR (2015) Hemostatic disorders of the menopausal period: the role of microRNA. Prz Menopauzalny 2:144–148

    Google Scholar 

  18. Yavropoulou MP, Anastasilakis AD, Makras P, Tsalikakis DG, Grammatiki M, Yovos JG (2017) Expression of microRNAs that regulate bone turnover in the serum of postmenopausal women with low bone mass and vertebral fractures. Eur J Endocrinol 176:169–176

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149, Münster, Deutschland

    Linda Sarah Ross, Martin Götte &  Ludwig Kiesel

Authors
  1. Linda Sarah Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Götte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ludwig Kiesel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ludwig Kiesel.

Ethics declarations

Interessenkonflikt

L.S. Ross, M. Götte und L. Kiesel geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

L. Kiesel, Münster

A.O. Mueck, Tübingen

P. Stute, Bern

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ross, L.S., Götte, M. & Kiesel, L. Sind miRNAs als Biomarker geeignet?. Gynäkologische Endokrinologie 16, 205–208 (2018). https://doi.org/10.1007/s10304-018-0193-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10304-018-0193-z

Search

Navigation